e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Novel in vitro and animal models to study lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice
K. Arimura, K. Aoshiba, T. Tsuji, J. Tamaoki (Tokyo, Ibaraki, Japan)
Source:
Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Session:
Novel in vitro and animal models to study lung diseases
Session type:
Thematic Poster Session
Number:
530
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Arimura, K. Aoshiba, T. Tsuji, J. Tamaoki (Tokyo, Ibaraki, Japan). Chronic low-grade systemic inflammation causes DNA damage in the lungs of mice. Eur Respir J 2013; 42: Suppl. 57, 530
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Implication of microRNA-148b in chronic obstructive lung disease of betaENaC-overexpressing mice
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Autoimmune induction of a COPD-like inflammatory phenotype in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
A transient receptor potential melastin-2 deficiency significantly worsens the fibrotic response to bleomycin in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Systemic inflammation in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Inflammation in COPD: a link to systemic comorbidities
Source: Eur Respir Rev 2007; 16: 91-97
Year: 2007
Case control study of chronic obstructive pulmonary disease and its progression
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013
Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
Source: Eur Respir J 2008; 31: 1334-1356
Year: 2008
Comparison of two murine models of acute and chronic hypersensitivity pneumonitis due to pigeon serum exposure
Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models
Year: 2015
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Impact of chronic bronchial infection on the lungs and beyond
Source: Eur Respir Monogr 2013; 60: 46-57
Year: 2013
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Chronic intermittent hypoxia induces liver injury in mice with diet induced obesity via TLR4/MyD88/MAPK/NF-kB signaling pathways
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016
The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
The novel compound Sul-121 inhibits inflammation in experimental models of chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice
Source: International Congress 2016 – Immune responses in the lung
Year: 2016
Increased laminin deposition and expression of TGF-beta in bronchial biopsies of children with chronic obstructive respiratory diseases
Source: Annual Congress 2013 –Paediatric bronchology
Year: 2013
Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Nintedanib reduces bleomycin-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept